GXI Interactions
GXI 交互
基本信息
- 批准号:10628511
- 负责人:
- 金额:$ 60.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcuteAcute Respiratory Distress SyndromeAdultAfricanAfrican American populationAgeAge YearsAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmerindianAnosmiaArgentinaBiologicalCOVID-19COVID-19 impactCOVID-19 morbidityCOVID-19 mortalityCOVID-19 patientCaucasiansCause of DeathChildChinaCitiesComplexDataDementiaDiseaseElderlyEncephalopathiesEnvironmental Risk FactorEthnic OriginEtiologyFosteringFutureGene ExpressionGene FrequencyGenesGeneticGenetic VariationGenotypeHeritabilityHypoxic-Ischemic Brain InjuryImpaired cognitionIndividualInfectionJointsMeasuresMethodsMexican AmericansModelingMorbidity - disease rateNative AmericansNerve DegenerationNervous System PhysiologyNeurobiologyNeurocognitiveNeurologicNeuronsNeuropathyParkinson DiseasePathologicPathologyPathway interactionsPatientsPersonsPhenotypePneumoniaPopulationPopulation HeterogeneityPredispositionPrevalenceProteinsPublic HealthPuerto RicanRecording of previous eventsRiskSARS-CoV-2 infectionSouth AmericanStrokeSymptomsTestingTimeVariantacute hypoxemic respiratory failureaging brainblood-based biomarkerbrain basedcohortdementia riskdesignendophenotypeexperiencegenetic architecturegenetic epidemiologygenome-widehealth care service utilizationhigh riskhuman old age (65+)identity by descentimprovedinsightinter-individual variationmortalitynervous system disorderneuroimagingneuropsychiatrypandemic diseaseresponsewhole genome
项目摘要
PROJECT SUMMARY/ABSTRACT
By 2050, more than 2 billion people worldwide will be over the age of 65, with older adults outnumbering
children for the first time in recorded history. This predicted major demographic shift highlights the importance
of improving our understanding of factors that contribute to healthy brain aging. Currently, the biological bases
of brain aging are poorly understood. Brain aging (often focused on cognitive decline) is characterized by
numerous phenotypes that undoubtedly involve multiple environmental and genetic factors. Overtly
pathological brain aging is seen in major neurological diseases such as Alzheimer’s disease and related
dementias (ADRD); the prevalence of ADRD is expected to double every 20 years. On top of this existing
public health crisis, we are now experiencing a global pandemic that appears to negatively influence
neurological function. Growing evidence indicates that SARS-CoV-2 infection causes neurological
complications of short-term consequence including acute neuropathy, encephalopathy, anosmia, and
hypoxic/ischemic brain injury, and longer-term consequences including cognitive impairment and
neuropsychiatric disturbances.
The interindividual variation in the neurobiological responses to SARS-CoV-2 is marked. As with most
complex phenotypes, causal determinants likely include both genetic and environmental factors. However, no
genetic epidemiological study has yet considered differential neurophenotypic response to infection. Thus,
delineating the genetic architecture of ADRD-relevant neurophenotypic responses to SARS-CoV-2 will offer
important biological insights, which in turn could provide strategies for fostering healthy brain aging in the
presence of future infectious challenges. Our project will assess the genetic basis of ADRD-relevant
endophenotypic response (across a two year period with three examinations) to SARS-CoV-2 infection in a set
of older (>60 years of age) adults from diverse populations (Amerindians from Argentina [ n=3000], US Native
Americans [n=250], Mexican Americans [n=500], Puerto Ricans [n=125], African Americans [n=125], and
Africans [n=300]) using whole genome sequence (WGS) data in a case/control design (75% post-infection
cases, 25% never infected controls). The data generated will enable estimating the importance of genetics in
disease response and the identification of key genes involved in the response. Our specific aims are to: 1)
detect genetic influences on endophenotypic responses to SARS-CoV-2 infection using WGS data through
testing for genotype×infection interaction in neurocognitive measures (neurocognitive measures, neuroimaging
measures, and blood-based biomarkers); 2) search for sequence variation in genes and gene pathways
influencing response to SARS-CoV-2 infection; and 3) test whether between-population variation in mean
responses to infection has a genetic component. This project represents the genetic component of a large,
integrated U19 application to examine the effect of COVID-19 on risk for ADRD in understudied ethnicities.
Through the proposed project, we will identify causal genetic factors that underly differential response in ADRD
risk to COVID-19.
项目总结/摘要
到2050年,全世界将有超过20亿人年龄超过65岁,老年人的人数超过65岁。
在有记载的历史上第一次。这一预测的重大人口变化凸显了
来提高我们对健康大脑老化因素的理解。目前,生物基地
大脑衰老的机制还知之甚少大脑老化(通常集中在认知能力下降)的特点是:
许多表型,无疑涉及多种环境和遗传因素。公然
病理性脑老化见于主要的神经系统疾病,如阿尔茨海默氏病和相关疾病。
痴呆症(ADRD);预计ADRD的患病率每20年翻一番。在现有的
公共卫生危机,我们现在正在经历一场全球流行病,
神经功能越来越多的证据表明,SARS-CoV-2感染会导致神经系统疾病,
短期后果并发症包括急性神经病变、脑病、嗅觉丧失和
缺氧/缺血性脑损伤,以及包括认知障碍和
神经精神紊乱
对SARS-CoV-2的神经生物学反应的个体间差异显著。如同大多数
复杂的表型,因果决定因素可能包括遗传和环境因素。但没有
遗传流行病学研究尚未考虑对感染的不同神经表型反应。因此,在本发明中,
描述对SARS-CoV-2的ADRD相关神经表型反应的遗传结构将提供
重要的生物学见解,这反过来又可以为促进健康的大脑老化提供策略,
未来的传染病挑战。我们的项目将评估ADRD相关的遗传基础,
在一个集合中,对SARS-CoV-2感染的内表型反应(在两年期间进行三次检查)
来自不同人群的老年人(>60岁)(来自阿根廷的美洲印第安人[ n=3000],美国原住民
美国人[n=250]、墨西哥裔美国人[n=500]、波多黎各人[n=125]、非洲裔美国人[n=125]和
非洲人[n=300]),采用病例/对照设计中的全基因组序列(WGS)数据(75%感染后
25%从未感染对照组)。所产生的数据将有助于估计遗传学在以下方面的重要性:
疾病反应和识别参与反应的关键基因。我们的具体目标是:1)
使用WGS数据检测对SARS-CoV-2感染的内表型反应的遗传影响,
在神经认知测量中检测基因型×感染相互作用(神经认知测量,神经影像学
测量和基于血液的生物标志物); 2)寻找基因和基因途径中的序列变异
影响对SARS-CoV-2感染的反应;以及3)测试平均值的群体间变异是否
对感染的反应有遗传因素。这个项目代表了一个大型的,
整合U19应用程序,以检查COVID-19对未充分研究的种族中ADRD风险的影响。
通过这个项目,我们将确定ADRD中差异反应的遗传因素
COVID-19的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Blangero其他文献
John Blangero的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Blangero', 18)}}的其他基金
Experimental Cellular Approaches to Genotype × Environment Interaction
基因型与环境相互作用的实验细胞方法
- 批准号:
10630638 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Research Project 2 - Genomic Approaches to Pollutome Effects on Risk of Major Depression in Hispanic Pedigrees
研究项目 2 - 污染组学方法对西班牙裔谱系中重度抑郁症风险的影响
- 批准号:
10749788 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Shared Genetic and Environmental Influences on Age-Related Hearing Loss, Cognitive Decline, and Dementia Risk
遗传和环境对与年龄相关的听力损失、认知能力下降和痴呆风险的共同影响
- 批准号:
10658077 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction
使用基因校正鉴定墨西哥裔美国人家庭脂肪肝中的暴露组
- 批准号:
10057266 - 财政年份:2018
- 资助金额:
$ 60.95万 - 项目类别:
Analysis Core Rio Grande Valley AD-RCMAR
里奥格兰德河谷分析核心 AD-RCMAR
- 批准号:
10241359 - 财政年份:2018
- 资助金额:
$ 60.95万 - 项目类别:
Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction
使用基因校正鉴定墨西哥裔美国人家庭脂肪肝中的暴露组
- 批准号:
10307087 - 财政年份:2018
- 资助金额:
$ 60.95万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 60.95万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 60.95万 - 项目类别:














{{item.name}}会员




